CPRT AI Stock Analysis – Buy, Hold, or Avoid?
Copart, Inc. (CPRT)
Fundamentals
Copart, Inc. (CPRT) demonstrates robust financial health, strong and consistent earnings growth, and industry-leading profitability. While recent stock price volatility and a sharp pullback from 52-week highs warrant caution, the business fundamentals remain resilient, underpinned by reliable revenue streams and disciplined cost controls.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
2.09% YoY
Q1 2026
Net Income
-1.03% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 1.2B | 1.1B | 1.2B | 1.2B | 1.1B | 1.1B |
| Revenue Growth YoY | +2.09% | -3.58% | +0.72% | +5.25% | +7.49% | +14.03% | +12.39% | +7.16% |
| Net Income | 402.4M | 350.7M | 403.7M | 396.4M | 406.6M | 387.4M | 362.1M | 322.6M |
| Net Income Growth YoY | -1.03% | -9.47% | +11.50% | +22.87% | +6.36% | +18.97% | +8.89% | -7.25% |
| EPS | $0.43 | $0.36 | $0.42 | $0.41 | $0.42 | $0.40 | $0.38 | $0.34 |
| EPS Growth YoY | +2.38% | -10.00% | +10.53% | +20.59% | +5.00% | +17.65% | +8.57% | -5.56% |
Profitability Metrics
Technical Analysis
CPRT is currently in a strong downtrend with price below key moving averages and a death cross in place, indicating bearish technical conditions. The RSI sits in a neutral zone but momentum is weak, while MACD signals lean bearish. The stock is testing critical support around $29.73 to $30.01, with resistance between $30.12 and $30.47 acting as an immediate barrier for any rebound attempts.
No extreme reading
Price in downtrend
Range-bound market
50 below 200 - bearish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Copart, Inc. (CPRT) demonstrates robust financial health, strong and consistent earnings growth, and industry-leading profitability. While recent stock price volatility and a sharp pullback from 52-week highs warrant caution, the business fundamentals remain resilient, underpinned by reliable revenue streams and disciplined cost controls.
Latest Earnings
Q1 2026 Earnings (Apr 30, 2026)
Earnings Per Share (EPS)
Actual
$0.43
Estimated
$0.41
Surprise
+$0.02
Surprise %
+5.83%
Revenue
Actual
$1.24B
Estimated
$1.19B
Surprise
+$42.33M
Surprise %
+3.54%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $0.43 | $0.36 | $0.41 | $0.41 | $0.42 | $0.40 | $0.37 | $0.33 |
| EPS (Estimated) | $0.41 | $0.39 | $0.39 | $0.36 | $0.42 | $0.37 | $0.37 | $0.36 |
| EPS Surprise | +$0.02 | -$0.03 | +$0.02 | +$0.05 | +$0.00 | +$0.03 | +$0.00 | -$0.03 |
| % Diff | +5.8% | -8.3% | +5.2% | +13.5% | +0.8% | +7.6% | +0.0% | -8.3% |
| Revenue | ||||||||
| Revenue (Actual) | $1.24B | $1.12B | $1.16B | $1.13B | $1.21B | $1.16B | $1.15B | $1.07B |
| Revenue (Estimated) | $1.19B | $1.15B | $1.18B | $1.14B | $1.23B | $1.13B | $1.1B | $1.07B |
| Revenue Surprise | +$42.33M | -$27.13M | -$23.64M | -$11.74M | -$17.1M | +$31.96M | +$47.32M | -$5.14M |
| % Diff | +3.5% | -2.4% | -2.0% | -1.0% | -1.4% | +2.8% | +4.3% | -0.5% |
Valuation
Copart Inc. (CPRT) is currently trading at valuation multiples significantly below its historical averages and many industry peers, suggesting a potential undervaluation. While its profitability metrics remain strong, with robust margins and returns, revenue growth has been modest. Analyst sentiment is mixed but leans towards a moderate buy with an average price target implying nearly 45-48% upside.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 19.25 | 28.18 | 25.60 | 27.64 | 36.33 | 36.21 | 33.86 | 38.48 |
| Price to Sales | 25.62 | 35.00 | 36.03 | 38.96 | 48.67 | 48.04 | 43.23 | 47.12 |
| Price to Book | 3.61 | 4.01 | 4.34 | 4.77 | 6.72 | 6.73 | 6.28 | 6.69 |
| Enterprise Value to EBITDA | 50.68 | 69.00 | 68.26 | 77.37 | 101.74 | 101.81 | 91.09 | 106.69 |
| Enterprise Value to Revenue | 22.99 | 30.54 | 31.59 | 36.59 | 46.80 | 45.27 | 40.10 | 45.81 |
Sentiment & Analyst Ratings
Copart's market sentiment is currently mixed but leaning neutral to cautiously optimistic, supported by solid Q3 earnings that beat expectations and strong international growth. Analysts generally maintain a 'Hold' consensus with several projecting significant upside based on undervaluation and expansion prospects, while retail sentiment remains subdued and neutral. Recent stock price declines and concerns about unit volume declines and insurance cycle sensitivity contribute to cautious investor psychology.
Analyst Recommendations
Risk Assessment
Copart exhibits a strong financial position characterized by exceptionally high liquidity and very low leverage, supporting its ability to withstand operational pressures. However, emerging structural weaknesses in insurance-related volumes and competitive pressures in new international markets introduce notable uncertainty. While the business benefits from sector tailwinds related to total loss vehicle frequency, several operational and regulatory risks should be carefully monitored.
Liquidity & Solvency
Frequently Asked Questions about CPRT
AI Answers: Common Questions About CPRT
Get AI-powered answers to the questions investors ask most about Copart, Inc.
Copart is trading at a P/E of 18.78 (well below its 5-year median in the mid-30s) and an EV/EBITDA of 11.6, with strong margins and cash flows, suggesting undervaluation. However, the stock is in a technical downtrend and just off its 52-week low ($29.46), so while long-term value is compelling, short-term entry is risky without a reversal signal.
Unless your horizon is short-term, there is little fundamental reason to sell; the business remains strong and undervalued. However, if you are a trader or cannot tolerate further downside, technicals indicate continued weakness and you may consider reducing exposure until a trend reversal is confirmed.
The biggest risks are structural volume declines in insurance vehicle flows, execution and competition challenges in new international markets, and ongoing regulatory scrutiny (e.g., DOJ investigation). Despite a current ratio above 7 and debt-to-equity near 0.01, operational and market risks could pressure earnings and sentiment.
Analyst price targets average $44-$45, implying 45-48% upside from current levels. Technically, immediate support is $29.73-$30.01, with resistance at $30.12-$30.47 and a major technical hurdle at $32.6 (50 SMA); a break above these could signal a trend change.
The stock is undervalued: P/E is 18.78 (vs. historical mid-30s), EV/EBITDA is 11.6 (down from 50-100x), and P/S is around 6x, all below historical and peer averages. This reflects market caution but offers upside if growth stabilizes.
Copart is fundamentally strong, with gross margins above 46%, net margins above 33%, double-digit EPS growth, and a fortress balance sheet (current ratio >7, debt-to-equity ~0.01). Organic growth and cash conversion are excellent, supporting long-term sustainability.
Technically, the stock is in a strong downtrend with a death cross (50 SMA below 200 SMA), price below all major moving averages, and RSI at 38.9 (neutral to oversold). Support is at $29.73-$30.01, but no bullish reversal is confirmed; traders should wait for a break above $30.5 or $32.6 for a trend change.
Key catalysts include upcoming earnings (which have recently beaten expectations), stabilization or growth in insurance vehicle volumes, and successful international expansion. Watch for technical reversals, analyst upgrades, or positive macro developments in the insurance/auto sector.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.